Tag Archives: BMY

No Comments

CBOE Mid-Day Update 4.28.15

Volatility as an asset class Merck (MRK) is recently up $2.90 to $60 on better than expected Q1 results and outlook. May call option implied volatility is at 18, June, July and October is at 17; compared to its 26-week average of 19. Bristol-Myers (BMY) is recently down to $64.35 on better than expected Q1 […]


Next Week in Weeklys – 1/20/2014

We only have four working market days this coming week, but all that does is compress a lot of earnings releases into a short week.  More than thirty stocks report their earnings this coming week and looking at the list it is tough to figure out which to highlight.  Also, beyond the names on the […]